Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2026-03-02 @ 4:37 PM
Study NCT ID:
NCT02769832
Status:
COMPLETED
Last Update Posted:
2025-07-29
First Post:
2016-01-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nab-Paclitaxel With Gemcitabine for Relapsed Small Cell Cancer
Sponsor:
Muhammad Furqan
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
201512799
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |